TradingKey – CVS Health (CVS) delivered an eighth consecutive quarter of results that topped market expectations, yet failed to win over investors. On November 4, the company announced plans to split its business into two independent publicly traded companies in the first half of 2028. Following the announcement, its shares plunged 12.5% to near six-month lows. Although both third-quarter revenue and adjusted earnings per share exceeded Wall Street estimates and the company raised its future earnings guidance, investors remain skeptical about the breakup plan’s lack of concrete financial arrangements, the potential loss of synergies, and ongoing regulatory pressures.

Judging from its third-quarter earnings report, CVS’s operational…